Investigation of Antimicrobial Resistance, Global Challenges and Solutions

Abstract

Antimicrobial resistance (AMR) has emerged as one of the most pressing global health threats of the 21st century, undermining decades of medical and scientific progress. As bacteria, viruses, fungi, and parasites develop resistance to existing treatments, common infections become increasingly difficult to manage, leading to higher mortality rates, prolonged illnesses, and escalating healthcare costs. This review synthesizes current research on the drivers, global impacts, and possible solutions to the growing challenge of AMR, emphasizing its multifaceted nature and the need for coordinated international action. Key contributors to AMR—including the misuse and overuse of antimicrobials in human medicine, agricultural practices, inadequate infection prevention measures, and the slow pace of drug development—have intensified the spread of resistant pathogens across borders and ecosystems.The global challenges posed by AMR extend beyond public health, affecting economic productivity, food security, and social stability. Low- and middle-income countries face a disproportionate burden due to limited diagnostic capacity, insufficient regulatory frameworks, and poor access to quality medicines. Moreover, the increasing prevalence of multidrug-resistant organisms in clinical settings threatens the effectiveness of routine surgeries, cancer therapies, and neonatal care, pushing healthcare systems toward potential crisis.In response to these threats, researchers and policymakers are exploring a wide range of solutions. These include strengthening antibiotic stewardship programs, expanding surveillance systems, investing in rapid diagnostics, and developing new antimicrobial agents through public–private partnerships. Novel alternatives such as bacteriophage therapy, antimicrobial peptides, and microbiome-based interventions also show promising potential. Additionally, global initiatives led by organizations such as the WHO encourage countries to implement comprehensive action plans to mitigate AMR through a One Health approach that integrates human, animal, and environmental health strategies.Ultimately, addressing AMR requires sustained political commitment, interdisciplinary collaboration, and innovation. By examining both the challenges and emerging solutions, this review highlights the urgency of collective global action to preserve the effectiveness of life-saving antimicrobials for future generations.